Icariin ameliorates minimal change disease by regulating the mitochondrial dysfunction pathway: an integrated strategy of network pharmacology, bioinformatics, and experimental validation.

Front Pharmacol · 2025 · PMC12425968 · PMID 40949127

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

MCD accounts for approximately 10%–15% of all cases of primary nephrotic syndrome in adults and 70%–90% of all cases in children, with an increasing trend annually ( Vivarelli et al., 2017 ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.